Travere Therapeutics Executives Sell Shares Amidst Market Volatility

Travere Therapeutics, Inc. [TVTX] has announced that its Chief Financial Officer, Christopher R. Cline, has sold 1,635 shares at a price of $32.14 per share on February 4, 2026, and also sold 110 shares at $32.9 per share on the same date. The company's Chief Medical Officer, Jula Inrig, has also sold 1,547 shares at $32.11 per share on February 4, 2026, and 232 shares at $32.85 per share on the same date. Furthermore, the Chief Legal Officer and General Counsel, Elizabeth E. Reed, has sold 2,485 shares at $32.07 per share on February 4, 2026, and 509 shares at $32.74 per share on the same date.